Pay in 4 interest-free payments of $6.75 Learn more
Ships within 48 hours · Estimated delivery Sep 11 - Sep 16
Sometimes they haven't thought to mention it
Methodology The patent filings/families are based on data from PatBase, a patent data and analytics platform, The search criteria were developed using combinations of keywords and classifications
All interventions were compared with current use of SGLT2is (20% of the total population) and GLP-1 RAs (5% of the total population)
Recently, IL-12/IL-23 inhibitors have been introduced as a new class of drugs for PsA management, with evidence suggesting that their efficacy is less influenced by body weight
However, they are also effective independently
US$ 28.85
US$ 20.07
US$ 27.00
US$ 26.84
US$ 27.68
